Methenamine hippurate and Ampyra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methenamine hippurate (methenamine hippurate) and Ampyra (dalfampridine). Common drug interactions include neurogenic bladder among females and aphasia among males.

The phase IV clinical study analyzes what interactions people have when they take Methenamine hippurate and Ampyra. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Methenamine hippurate?

Methenamine hippurate has active ingredients of methenamine hippurate. It is often used in urinary tract infection. eHealthMe is studying from 1,158 Methenamine hippurate users. Check the latest studies of Methenamine hippurate.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.

On Jul, 17, 2026

88 people who take Methenamine hippurate and Ampyra together, and have interactions are studied.

Methenamine hippurate and Ampyra drug interactions.

What are the common drug interactions of Methenamine Hippurate and Ampyra, by gender? *:

female:

Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Pneumonia
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Stress
Upper respiratory tract infection
Alopecia (absence of hair from areas of the body)
Bedridden
Decreased appetite
Diarrhoea

male:

Aphasia (damage to the parts of the brain that control language)
Blood cholesterol increased
Chest discomfort
Chest pain
Dizziness
Dizziness exertional
Hyperhidrosis (abnormally increased sweating)
Hypokinesia (decreased bodily movement)
Insomnia (sleeplessness)
Palpitations (feelings or sensations that your heart is pounding or racing)

What are the common drug interactions of Methenamine Hippurate and Ampyra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cyst (a closed sac)
Fall
Fatigue (feeling of tiredness)
Pain

40-49:

Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
B-lymphocyte abnormalities (abnormal population of b lymphocytes in the blood, bone marrow, or tissues)
B-lymphocyte count decreased
Breast cyst
Pruritus (severe itching of the skin)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Peripheral swelling
Urinary tract infection staphylococcal
Anaphylactic reaction (serious allergic reaction)
Anger

50-59:

Abdominal pain
Asthenia (weakness)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Blood glucose increased
Contusion (a type of hematoma of tissue in which capillaries)
Depressed mood
Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)

60+:

Weight decreased
Aphasia (damage to the parts of the brain that control language)
Drug ineffective
Gait disturbance
Humerus fracture (injury to the upper arm bone)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Sinusitis (inflammation of sinus)
Fall
Balance disorder
Bedridden

What are the existing conditions these people have? *

Gait Disturbance: 35 people, 39.77%

* Approximation only. Some reports may have incomplete information.

Do you take Methenamine hippurate and Ampyra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously